Bordetella pertussis, Finland and France

Emerging Infectious Diseases

Volumn 12, Issue 6, 2006, Pages 987-989

  Caro, Valérie ^a,c,d   Elomaa, Annika ^b   Brun, Delphine ^a   Mertsola, Jussi ^b   He, Qiushui ^b   Guiso, Nicole ^a  

^a CNRS   (France)

^b UNIVERSITY OF TURKU   (Finland)

^c INSTITUT PASTEUR   (France)

^d French National Center of Reference of Whooping Cough and Other Bordetelloses   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; GENOMIC DNA; PERTACTIN; PERTUSSIS VACCINE;

ALPHA CHAIN; ARTICLE; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; FINLAND; FRANCE; FUNCTIONAL INDEPENDENCE MEASURE; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; MEDICAL RESEARCH; NONHUMAN; PERTUSSIS; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; VACCINATION;

EID: 33744927440     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1206.051283     Document Type: Article

References (15)

1. Wirsing von Konig CH, Halperin S, Riffelmann M, and Guiso N. Pertussis of adults and infants. Lancet Infect Dis.2002;2:744-50.
2. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, and Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. Jama.2003;290:2968-75.
3. Forsyth K, Tan T, von Konig CH, Caro JJ, and Plotkin S. Potential strategies to reduce the burden of pertussis. Aims, scope and findings of the global pertussis initiative. Pediatr Infect Dis J.2005;24:S69-74.
4. Mattoo S, and Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev.2005;18:326-82.
5. Weber C, Boursaux-Eude C, Coralie G, Caro V, and Guiso N. Polymorphism of Bordetella pertussis isolates circulating the last ten years in France, where a single effective whole-cell vaccine has been used for more than thirty years. J. Clin. Microbiol.2001;39:4396-4403.
6. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HGJ, Gaastra W, and Willems RJL. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: Temporal trends and evidence for vaccine-driven evolution. Infect. Immun.1998;66:670-5.
7. Gzyl A, Augustynowicz E, Van Loo I, and Slusarczyk J. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine.2002;20:299-303.
8. Fry NK, Neal S, Harrison TG, Miller E, Matthews R, and George RC. Genotypic variation in the Bordetella pertussis Virulence Factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect. Immun.2001;69:5520-8.
9. Mastrantonio P, Spigaglia P, van Oirschot H, van der Heide HGJ, Heuvelman K, Stefanelli P, et al. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiol.1999;145:2069-75.
10. Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, and Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect.2004;132:185-93.
11. Peppler MS, Kuny S, Nevesinjac A, Rogers C, De Moissac YR, Knowles K, et al. Strain variation among Bordetella pertussis isolates from Quebec and Alberta provinces of Canada from 1985 to 1994. J Clin Microbiol.2003;41:334-47.
12. Hardwick TH, Cassiday P, Weyant RS, Bisgard KM, and Sanden GN. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerging Infect. Dis.2002;8:44-9.
13. Elomaa A, Advani A, Donnelly D, Antila M, Mertsola J, Hallander H, et al. Strain variation among Bordetella pertussis isolates in Finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol.2005;43:3681-7.
14. Caro V, Njamkepo E, Van Amersfoorth SC, Mooi FR, Advani A, Hallander HO, et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect.2005;7:976-82.
15. Njamkepo E, Rimlinger F, Thiberge S, and Guiso N. Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. Vaccine.2002;20:1290-4.